Light at Night & Melatonin
Bright days and dark nights maximize melatonin, an antioxidant linked to lower mortality and Alzheimer's protection.
Summary
In a UK Biobank study of 100,000+ people wearing light sensors, the most light at night was associated with up to 46% higher cardiometabolic mortality, while more daytime light was associated with roughly 20-40% lower mortality. Blue light shuts down melatonin, which sets circadian rhythm and also acts as an intracellular antioxidant and immune modulator; it declines with age as the pineal gland calcifies. Animal studies link melatonin to amyloid-beta clearance and reduced nanoplastic uptake, and small human trials show benefits on inflammation, oxidative stress, and performance after sleep loss. She calls light optimization the 'low-hanging fruit' for healthspan.
In 2024: 'I already prioritize sleep and take a low-dose, timed-release melatonin supplement.' Not listed in her Jan 2026 stack.From Do Microplastics Shorten Lifespan?
The evidence
-
Human trial
In a 2021 clinical trial in male athletes, 6 mg melatonin after 4-hour or 24-hour sleep deprivation improved balance, anaerobic power, and reaction time, but not after normal sleep.
-
Human trial
In an RCT in MS patients, melatonin improved heart rate variability and oxidative stress biomarkers.
Read the study Discussed in Longevity for the 99% -
Human obs.
In 100,000+ UK Biobank participants, the top 10% of night light exposure had 46% higher cardiometabolic and 30% higher other-cause mortality; top-half daytime light had ~20-40% lower mortality risk.
-
Human obs.
A 2021 study found outdoor light at night was associated with about 10% higher risk of coronary heart disease hospitalization and death.
-
Human obs.
Light pollution at night was associated with higher Alzheimer's prevalence, more strongly than alcohol abuse, kidney disease, depression, heart failure, or obesity.
Read the study Discussed in Alzheimer's Prevention Strategies -
Animal
Animal studies show melatonin helps clear amyloid-beta plaque and improves brain insulin signaling.
Read the study Discussed in Longevity for the 99%
Doses used in studies
Amounts reported in the research, not dosing recommendations.
| Dose | Context |
|---|---|
| 3-5 mg/night melatonin | Clinical trials in people with chronic conditions (PCOS, MS) |
| 6 mg melatonin | Male athletes after sleep deprivation |
| 300 mcg timed-release or 1.5 mg immediate/extended-release melatonin | Low-dose options she suggests for healthy middle-aged people |
| Bright light (e.g. 5,000 lux) during the day | Significantly increases nighttime melatonin; midday exposure shifts melatonin onset earlier |
| Dim, orange-bulb lamps and no screens for 2 hours before bed; dark bedroom | Her suggested one- to two-week experiment |
Cautions
- High melatonin doses likely aren't needed for healthy middle-aged people; timed-release forms better mimic natural production.
- Daytime melatonin effects vary: some people feel sleepy, others report an anti-anxiety effect (anecdotal).
- Benzodiazepine sleep aids are hard to quit, and zolpidem has been linked to higher dementia risk and reduced glymphatic clearance.